RecruitingNot Applicable

EUS-guided Entero-biliary Anastomosis for Therapeutic Access in Benign Biliary Obstructions

Spain50 participantsStarted 2021-06-01

Plain-language summary

Background: Transpapillary EUS-BD (rendezvous/antegrade) is gaining acceptance in BBO. The potential of transmural EUS-BD (hepaticogastrostomy/choledochoduodenostomy) in complex BBO warrants study. Aims: To assess feasibility and efficacy of TEA using transmural covered self-expandable metal-stents (cSEMS) to provide interval biliary drainage and create TAF for biliary endotherapy under cholangioscopy or fluoroscopy in BBO not amenable to ERCP.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * • Consecutive patients ≥ 18 years old. * Benign biliary obstruction. * ERCP failed or where ERCP could not be performed due to surgically-altered anatomy Exclusion Criteria: * • Refusal to sign the informed consent. * Malignant biliary obstruction * Coagulopathy (INR\>1.5) or trombocytopenia (\<50,000 platelets/mm3) uncorrectable. * Inability to tolerate the sedation necessary for the examination. * Pregnancy or lactation. * Unable to follow-up

What they're measuring

Clinical success

Timeframe: 1 year

Trial details

NCT IDNCT05246657

SponsorHospital del Rio Hortega

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2026-07-01

Contact for this trial

Carlos Maroto Martín, PI

983420400 cmarotom@saludcastillayleon.es

View on ClinicalTrials.gov More Cholangiopancreatography, Endoscopic Retrograde trials